Skip to main content
Full access
LETTER
Published Online: 1 October 2008

Mania in a Patient with Wilson’s Disease Awaiting Liver Transplant

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor : Wilson’s disease is associated with neuropsychiatric disorders such as psychosis, depression, and movement disorders. 1 Mania is an uncommon neuropsychiatric manifestation in Wilson’s disease. We report a young woman with Wilson’s disease who developed manic symptoms while awaiting a liver transplant.

Case Report

Miss AC, a 19-year-old woman, had been diagnosed with Wilson’s disease 2 years before the onset of her neuropsychiatric manifestations. She had developed ascites and other features suggestive of chronic liver disease. Her liver function tests, serum ceruloplasmin levels, urine copper levels, and serum copper levels were suggestive of Wilson’s disease. An ultrasound of the abdomen revealed a cirrhotic liver with portal hypertension. A brain MRI did not reveal any abnormality. A slit lamp examination done by the ophthalmologist revealed bilateral Kayser-Flescher rings, and she was started on D-penicillamine, 750 mg/day. Since there was a progressive deterioration in her liver function, a liver transplant was advised by the gastroenterologist. Due to the pending investigations of the patient, the liver transplant was planned at a later date and her mother gave consent for partial liver donation. During this period, she developed insomnia, increased talkativeness and increased activity. She had no past or family history of psychiatric illness.
The patient was transferred to psychiatry for management of these behavioral problems. Her mental status examination revealed overfamiliarity, distractibility, euphoric affect, increased psychomotor activity, and delusions of grandiosity with poor insight and judgment. She was started on a regimen of tablet haloperidol, 10 mg per day, in divided doses along with tablet promethazine, 15 mg, in divided doses. The dose of haloperidol was increased to 20 mg in divided doses after which she had significant extrapyramidal symptoms. Therefore the dosage was decreased to 10 mg per day; on reevaluation after 1 week her symptoms had decreased considerably. She was discharged and prescribed haloperidol, 7.5 mg per day, in divided doses and advised to have close follow-up. The patient is well maintained on a regimen of haloperidol, 7.5 mg/day on follow-up.
Mood stabilizers like sodium valproate and carbamazepine were not started because of poor hepatic function and because elevated fasting blood glucose levels made atypicals a poor choice in this woman. Considering the possibility of renal tubular acidosis in Wilson’s disease and a history of polyuria, treatment with lithium carbonate was also withheld. 1 Patients with Wilson’s disease are exquisitely sensitive to extrapyramidal side effects, and the dose titration should be gradual if typical antipsychotics are used, and they should be started at a lower dose. 2 There are no specific guidelines regarding the treatment of neuropsychiatric manifestations in Wilson’s disease. Medications for psychosis and mania that have been used include quetiapine, clozapine and haloperidol, as well as ECT. 1, 3 There is a paucity of literature available regarding the treatment options in psychiatrically ill patients with Wilson’s disease. Multi-system involvement in Wilson’s disease can make the traditional medications difficult to use in these patients, and treatment regimens may need to be individualized.

References

1.
Ala A, Walker AP, Ashkan K, et al: Wilson’s disease. Lancet 2007; 369:397–408
2.
Lauterbach EC, Cummings JL, Duffy J, et al: Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington’s, Wilson’s, and Fahr’s diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 1998; 10:249–266
3.
Kulaksizoglu IB, Polat A: Quetiapine for mania with Wilson’s disease. Psychosomatics 2003; 44:438–439

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 501 - 502
PubMed: 19196945

History

Published online: 1 October 2008
Published in print: Fall, 2008

Authors

Affiliations

Sunny T. Varghese, M.B.B.S., M.D.
Assistant Professor, Department of Psychiatry
Dinesh Narayanan, M.B.B.S., D.P.M., M.D.
Professor, Department of Psychiatry
Deepa Dinesh
Medical Student, Department of Psychiatry, Amrita Institute of Medical Sciences and Research Centre, Cochin, Kerala, India

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share